Deep Braining...
TendieTensor TendieTensor
You’re browsing as
Guest
Free Preview
Sign in/sign up to unlock all features.

Banzai International, Inc. Class A Common Stock (BNZI)
Banzai International, Inc. Class A Common Stock
XNAS:BNZI
1.24
-4.62%

Ask
$1.25 - 100.00
Bid
$1.21 - 150.00
Low
$1.24
High
$1.27
Open
$1.26
Prev Close
$1.3
52W High
27
52W Low
1.09
Volume
54435
Avg Vol (3m)
526103.5
Float
4996091.28
Chart
TendieTensor AI Analysis

Company
Asset Type: Common Stock
SIC Code: 7372
Sector: Technology Services
Industry: Packaged Software
Date Listed: 12/15/2023
Primary Exchange: XNAS

Banzai International Inc is a marketing technology (MarTech) company that produces data-driven marketing and sales solutions for businesses of all sizes. Its mission is to help its customers accomplish their mission by enabling marketing, sales and customer engagement outcomes. The company has two reportable operating segments, Banzai Operating and OpenReel. The company's segments deliver SaaS tools that leverage data, analytics, and AI to provide marketing and sales solutions for business of all size. it derives maximum revenue from Banzai Operating segment. Geographically, it operates in Americas, Europe, Middle East and Africa (EMEA), and Asia Pacific.

Phone: (206) 414-1777
Address: 435 Ericksen Ave Ne
Address 2: Suite 250
City: Bainbridge Island
State: WA
Postal Code: 98110
TendieTensor AI Analyst Recommendation:
Fundamentals
Total Employees:
28
P/E (TTM)
-0.080000
P/B (TTM)
1.243820
EPS
-1.44
Round Lot
100
Composit FIGI
BBG00YG9XLK3
Share Class FIGI
BBG00YG9XMG6
Share Class Shares Outstanding
3.47M
Weighted Shares Outstanding
6.19M

Technicals
RSI (14)
MACD Line
MACD Signal
SMA 20
SMA 50
EMA 50
Trend
Short Interest
Days to Cover
Higher = harder to cover
Short Interest Δ
Prev: —
Short Volume Ratio (Today)
5D avg:
Squeeze Score (0–100)
Discussion
Login to participate in discussions.
Recent News
Related Stocks

Based on the portfolios of people who own BNZI. This is a list generated by trading data from 3rd party trading platforms, and it's not a recommendation.